Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers.

Fernandez-Puente P, González-Rodríguez L, Calamia V, Picchi F, Lourido L, Camacho-Encina M, Oreiro N, Rocha B, Paz R, Marina A, García C, Blanco FJ, Ruiz-Romero C.

Mol Cell Proteomics. 2019 Jul 27. pii: mcp.RA119.001554. doi: 10.1074/mcp.RA119.001554. [Epub ahead of print]

2.

Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.

Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, Lopez-Lopez R, Gil-Moreno A, Alonso-Alconada L, Abal M.

J Proteome Res. 2019 Mar 1;18(3):1043-1053. doi: 10.1021/acs.jproteome.8b00750. Epub 2019 Jan 11.

PMID:
30585730
3.

In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis.

Cheleschi S, Calamia V, Fernandez-Moreno M, Biava M, Giordani A, Fioravanti A, Anzini M, Blanco F.

Int Immunopharmacol. 2018 Nov;64:86-100. doi: 10.1016/j.intimp.2018.08.025. Epub 2018 Aug 25.

PMID:
30153531
4.

Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.

Díaz-Díaz A, Casas-Pais A, Calamia V, Castosa R, Martinez-Iglesias O, Roca-Lema D, Santamarina I, Valladares-Ayerbes M, Calvo L, Chantada V, Figueroa A.

J Proteome Res. 2017 Aug 4;16(8):2773-2788. doi: 10.1021/acs.jproteome.7b00046. Epub 2017 Jul 21.

PMID:
28675930
5.

Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis.

Fernández-Puente P, Calamia V, González-Rodríguez L, Lourido L, Camacho-Encina M, Oreiro N, Ruiz-Romero C, Blanco FJ.

J Proteomics. 2017 Jan 30;152:216-225. doi: 10.1016/j.jprot.2016.11.012. Epub 2016 Nov 16.

PMID:
27865793
6.

Identification of Factors Produced and Secreted by Mesenchymal Stromal Cells with the SILAC Method.

Rocha B, Calamia V, Blanco FJ, Ruiz-Romero C.

Methods Mol Biol. 2016;1416:551-65. doi: 10.1007/978-1-4939-3584-0_33.

PMID:
27236695
7.

Lessons from the proteomic study of osteoarthritis.

Ruiz-Romero C, Fernández-Puente P, Calamia V, Blanco FJ.

Expert Rev Proteomics. 2015 Aug;12(4):433-43. doi: 10.1586/14789450.2015.1065182. Epub 2015 Jul 7. Review.

PMID:
26152498
8.

Simple Case Treatment Planning: Diastema Closure.

Calamia V, Pantzis A.

Dent Clin North Am. 2015 Jul;59(3):655-64. doi: 10.1016/j.cden.2015.03.010.

PMID:
26140972
9.

Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint.

Lourido L, Calamia V, Fernández-Puente P, Mateos J, Oreiro N, Blanco FJ, Ruiz-Romero C.

Proteomics Clin Appl. 2016 Jun;10(6):671-80. doi: 10.1002/prca.201400186. Epub 2015 Jun 15.

PMID:
25914226
10.

The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases.

Ruiz-Romero C, Calamia V, Albar JP, Casal JI, Corrales FJ, Fernández-Puente P, Gil C, Mateos J, Vivanco F, Blanco FJ.

J Proteomics. 2015 Sep 8;127(Pt B):406-13. doi: 10.1016/j.jprot.2015.01.023. Epub 2015 Feb 14. Review.

PMID:
25686859
11.

Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis.

Lourido L, Calamia V, Mateos J, Fernández-Puente P, Fernández-Tajes J, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2014 Dec 5;13(12):6096-106. doi: 10.1021/pr501024p. Epub 2014 Nov 21.

PMID:
25383958
12.

A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine.

Calamia V, Mateos J, Fernández-Puente P, Lourido L, Rocha B, Fernández-Costa C, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Sci Rep. 2014 Jun 10;4:5069. doi: 10.1038/srep05069.

13.

Secretome analysis of human mesenchymal stem cells undergoing chondrogenic differentiation.

Rocha B, Calamia V, Casas V, Carrascal M, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2014 Feb 7;13(2):1045-54. doi: 10.1021/pr401030n. Epub 2014 Jan 15.

PMID:
24400832
14.

Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties.

Calamia V, Lourido L, Fernández-Puente P, Mateos J, Rocha B, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Arthritis Res Ther. 2012 Oct 2;14(5):R202. doi: 10.1186/ar4040.

15.

Metabolic labeling of human bone marrow mesenchymal stem cells for the quantitative analysis of their chondrogenic differentiation.

Rocha B, Calamia V, Mateos J, Fernández-Puente P, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2012 Nov 2;11(11):5350-61. doi: 10.1021/pr300572r. Epub 2012 Oct 3.

PMID:
22989065
16.

Sequential depletion of human serum for the search of osteoarthritis biomarkers.

Fernández-Costa C, Calamia V, Fernández-Puente P, Capelo-Martínez JL, Ruiz-Romero C, Blanco FJ.

Proteome Sci. 2012 Sep 12;10(1):55. doi: 10.1186/1477-5956-10-55.

17.

Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF.

Mateos J, Lourido L, Fernández-Puente P, Calamia V, Fernández-López C, Oreiro N, Ruiz-Romero C, Blanco FJ.

J Proteomics. 2012 Jun 6;75(10):2869-78. doi: 10.1016/j.jprot.2011.12.042. Epub 2012 Jan 8.

PMID:
22245418
18.

Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes.

Calamia V, Fernández-Puente P, Mateos J, Lourido L, Rocha B, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Mol Cell Proteomics. 2012 Jun;11(6):M111.013417. doi: 10.1074/mcp.M111.013417. Epub 2011 Dec 27.

19.

Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells.

De la Fuente A, Mateos J, Lesende-Rodríguez I, Calamia V, Fuentes-Boquete I, de Toro FJ, Arufe MC, Blanco FJ.

Mol Cell Proteomics. 2012 Feb;11(2):M111.010496. doi: 10.1074/mcp.M111.010496. Epub 2011 Oct 17.

20.

Hsp90β inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes.

Calamia V, de Andrés MC, Oreiro N, Ruiz-Romero C, Blanco FJ.

BMC Musculoskelet Disord. 2011 Oct 17;12:237. doi: 10.1186/1471-2474-12-237.

21.

Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes.

Calamia V, Rocha B, Mateos J, Fernández-Puente P, Ruiz-Romero C, Blanco FJ.

J Proteome Res. 2011 Aug 5;10(8):3701-11. doi: 10.1021/pr200331k. Epub 2011 Jul 5.

PMID:
21692455
22.

Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism.

Cabral MP, Soares NC, Aranda J, Parreira JR, Rumbo C, Poza M, Valle J, Calamia V, Lasa I, Bou G.

J Proteome Res. 2011 Aug 5;10(8):3399-417. doi: 10.1021/pr101299j. Epub 2011 Jun 17.

PMID:
21612302
23.

Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes.

Calamia V, Ruiz-Romero C, Rocha B, Fernández-Puente P, Mateos J, Montell E, Vergés J, Blanco FJ.

Arthritis Res Ther. 2010;12(4):R138. doi: 10.1186/ar3077. Epub 2010 Jul 13.

24.

Hypoxia conditions differentially modulate human normal and osteoarthritic chondrocyte proteomes.

Ruiz-Romero C, Calamia V, Rocha B, Mateos J, Fernández-Puente P, Blanco FJ.

J Proteome Res. 2010 Jun 4;9(6):3035-45. doi: 10.1021/pr901209s.

PMID:
20387907
25.

Strategies to optimize two-dimensional gel electrophoresis analysis of the human joint proteome.

Ruiz-Romero C, Calamia V, Carreira V, Mateos J, Fernández P, Blanco FJ.

Talanta. 2010 Feb 15;80(4):1552-60. doi: 10.1016/j.talanta.2009.05.022. Epub 2009 May 22.

PMID:
20082814
26.

Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance.

Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martínez-Gomariz M, Fernández M, Blanco FJ.

Mol Cell Proteomics. 2009 Jan;8(1):172-89. doi: 10.1074/mcp.M800292-MCP200. Epub 2008 Sep 9.

27.

Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes.

Scotto d'Abusco A, Cicione C, Calamia V, Negri R, Giordano C, Grigolo B, Politi L, Scandurra R.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):847-52.

PMID:
18173918
28.

Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes.

Scotto d'Abusco A, Calamia V, Cicione C, Grigolo B, Politi L, Scandurra R.

Arthritis Res Ther. 2007;9(5):R104.

29.

Effects of intra-articular administration of glucosamine and a peptidyl-glucosamine derivative in a rabbit model of experimental osteoarthritis: a pilot study.

Scotto d'Abusco A, Corsi A, Grillo MG, Cicione C, Calamia V, Panzini G, Sansone A, Giordano C, Politi L, Scandurra R.

Rheumatol Int. 2008 Mar;28(5):437-43. Epub 2007 Oct 9.

PMID:
17924112
30.

Oligomerization of Sulfolobus solfataricus signature amidase is promoted by acidic pH and high temperature.

Scotto D'Abusco A, Casadio R, Tasco G, Giangiacomo L, Giartosio A, Calamia V, Di Marco S, Chiaraluce R, Consalvi V, Scandurra R, Politi L.

Archaea. 2005 Dec;1(6):411-23.

31.

Renal-cell carcinoma metastatic to the thyroid. Aspiration cytology and histologic findings.

Lasser A, Rothman JG, Calamia VJ.

Acta Cytol. 1985 Sep-Oct;29(5):856-8.

PMID:
3863434
32.

Anemia in chronic renal failure.

Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N.

Acta Endocrinol Suppl (Copenh). 1985;271:80-6. No abstract available.

PMID:
3865483
33.

Prolonged hypoglycemia during pentamidine therapy.

Raia JJ, Patton LR, Klein RA, Calamia V.

Clin Pharm. 1983 Nov-Dec;2(6):505-6. No abstract available.

PMID:
6653049
34.

A comparison of androgens for anemia in patients on hemodialysis.

Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N.

N Engl J Med. 1981 Apr 9;304(15):871-5.

PMID:
7010161

Supplemental Content

Loading ...
Support Center